Neet
Biotechnology Principles And Processes
NEET 2024 (Re-Examination)
MCQ+4 / -12024
Match List-I with List - II :
.tg {border-collapse:collapse;border-spacing:0;}
.tg td{border-color:black;border-style:solid;border-width:1px;font-family:Arial, sans-serif;font-size:14px;
overflow:hidden;padding:10px 5px;word-break:normal;}
.tg th{border-color:black;border-style:solid;border-width:1px;font-family:Arial, sans-serif;font-size:14px;
font-weight:normal;overflow:hidden;padding:10px 5px;word-break:normal;}
.tg .tg-c3ow{border-color:inherit;text-align:center;vertical-align:top}
.tg .tg-7btt{border-color:inherit;font-weight:bold;text-align:center;vertical-align:top}
.tg .tg-0pky{border-color:inherit;text-align:left;vertical-align:top}
| List - I | List - II | ||
|---|---|---|---|
| (A) | Genetically engineered Human Insulin | (I) | Gene therapy |
| (B) | GM Cotton | (II) | E. coli |
| (C) | ADA Deficiency | (III) | Antigen-antibody interaction |
| (D) | ELISA | (IV) | Bacillus thuringiensis |
Choose the correct answer from the options given below: